- Home
- STRS vs CVRX Comparison
STRS vs CVRX Comparison
Compare STRS & CVRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRS
- CVRX
- Stock Information
- Founded
- STRS 1992
- CVRX 2000
- Country
- STRS United States
- CVRX United States
- Employees
- STRS N/A
- CVRX N/A
- Industry
- STRS Homebuilding
- CVRX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- STRS Real Estate
- CVRX Health Care
- Exchange
- STRS Nasdaq
- CVRX Nasdaq
- Market Cap
- STRS 202.0M
- CVRX 185.8M
- IPO Year
- STRS N/A
- CVRX 2021
- Fundamental
- Price
- STRS $24.35
- CVRX $8.10
- Analyst Decision
- STRS
- CVRX Buy
- Analyst Count
- STRS 0
- CVRX 7
- Target Price
- STRS N/A
- CVRX $13.67
- AVG Volume (30 Days)
- STRS 8.7K
- CVRX 171.0K
- Earning Date
- STRS 11-12-2024
- CVRX 10-29-2024
- Dividend Yield
- STRS N/A
- CVRX N/A
- EPS Growth
- STRS N/A
- CVRX N/A
- EPS
- STRS N/A
- CVRX N/A
- Revenue
- STRS $42,935,000.00
- CVRX $44,393,000.00
- Revenue This Year
- STRS N/A
- CVRX $31.01
- Revenue Next Year
- STRS N/A
- CVRX $30.66
- P/E Ratio
- STRS N/A
- CVRX N/A
- Revenue Growth
- STRS 31.68
- CVRX 43.94
- 52 Week Low
- STRS $20.30
- CVRX $6.40
- 52 Week High
- STRS $30.66
- CVRX $33.14
- Technical
- Relative Strength Index (RSI)
- STRS 47.47
- CVRX 47.17
- Support Level
- STRS $22.84
- CVRX $6.79
- Resistance Level
- STRS $24.72
- CVRX $8.83
- Average True Range (ATR)
- STRS 1.18
- CVRX 0.54
- MACD
- STRS -0.09
- CVRX -0.02
- Stochastic Oscillator
- STRS 37.65
- CVRX 60.37
About STRS Stratus Properties Inc.
Stratus Properties Inc is a diversified real estate company operating in the United States. It is engaged in the acquisition, entitlement, development, management, operation and sale of commercial, multi- and single-family residential real estate properties, located in the Austin Texas area and other select markets in Texas. It operates its business through two segments namely, Real Estate Operations and Leasing Operations.
About CVRX CVRx Inc.
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.